Primary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health

University of South Wales240 enrolled

Overview

Prescribing lifestyle changes to patients who are at risk of cardiovascular disease, may be an extremely cost effective mechanism of improving health for the individual themselves and the NHS. It is already proven that positive lifestyle changes such as improved diet, increased physical activity, quitting smoking and reducing alcohol consumption can lower the risk of cardiovascular disease, as well as reduce the risk of all-cause mortality. P-PLAC2 (Primary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health) is a Phase II interventional study to determine the efficacy of a Lifestyle Prescription (LRx), from the viewpoint of patients and healthcare practitioners. The study uses a mixed methods design, and full study training and support will be provided to staff involved in the recruitment of patients, through to the behaviour change consultation, and end of study. If the study proves successful, a lifestyle prescription (LRx) could then be made available to support NHS staff throughout all disciplines (specifically those working with patients who are at risk of cardiovascular disease (CVD).

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

240

Conditions

Behavior Change Interventions Cardiovascular Diseases

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age 18 and over. * Able and willing to provide written informed consent. * Understands spoken and written English. Exclusion Criteria: * Participant is unwilling or unable to provide written informed consent. * Participant is pregnant. * Participant has a diagnosed psychological disorder. * Participant has a drug dependency. * Participant is housebound, or resides in a nursing home. * Participant has behavioural issues or learning difficulties.

Outcomes

Primary Outcomes

A prescription (LRx) being issued during a consultation

Number of a co- signed prescription (LRx) forms. Total number of forms to be co-signed = 120.

Time frame: During month 7 of the study

Patient view of the prescription (LRx) and consultation Questionnaire

Completed study questionnaires. Total number of questionnaires to be completed = 120. Responses will be recorded to gain feedback from the patient participants regarding their thoughts and feelings of their consultation with and without the intervention of the prescription (LRx) - control vs interventional group. Initials responses from the questionnaires will be compared with the participants 3mth post consultation questionnaire to establish if they acted upon the guidance offered, and if they're thought and feelings had changed during the time. Scale: 7 (minimum) to 41 (maximum). A lower value represents a better (more positive) outcome.

Time frame: During month 7 of the study

Healthcare Practitioner (HCP) view of the prescription (LRx) and consultation Questionnaire

Completed clinician questionnaires. Total number of questionnaires to be completed = 12. Responses will be recorded to gain feedback from the clinicians regarding their thoughts and feelings of their consultations with and without the intervention of the prescription (LRx). Sections 1 to 3: Section 1 Scale: 9 to 54 (a lower score represents a better, more positive outcome) Section 2 Scale: 8 to 48 (a lower score represents a better, more positive outcome) Section 3 Scale: 6 to 36 (a lower score represents a better, more positive outcome) Total score available: 23 to 138

Time frame: during month 7 of the study